Sequence-based prediction of linear autoepitopes involved in pathogenesis of IPAH and the corresponding organism sources of molecular mimicry

We proposed here a sequence-based approach predicting some microorganisms as possible sources of autoantigen-related molecular mimicry concerning Idiopathic Pulmonary Arterial Hypertension (IPAH) and related hypertension mostly accompanying autoimmune diseases and AIDS (APAH). This approach (SPECIES_VALENCE) processes the database occurrences of linear autoepitope-related short Dense Quasi-Pattern Sequences (DQPA) generated based on identities of important autoantigenic sequences. The corresponding enumeration comprises two types of statistical evaluations performed in each of eight proposed models. Based on this enumeration, we selected nine microorganisms, whereas revaluation of the obtained scoring values restricted Pseudomonas aeruginosa, Aspergillus fumigatus and the two co-infecting herpes viruses (Epstein Barr virus and cytomegalovirus) as most favourable. The results are discussed in terms of (a) the validity of increased DQPA occurrence in functionally correlated sequences, (b) the possible mechanisms leading to autoantibody response, (c) selected additional pathogenic effects of predicted microorganisms and (d) possible effects of cross-reactivities and immune tolerance.

[1]  K. Mizuguchi,et al.  Partner-Aware Prediction of Interacting Residues in Protein-Protein Complexes from Sequence Data , 2011, PloS one.

[2]  S. Venkatesan,et al.  Pulmonary hypertension in rheumatoid arthritis--relation with the duration of the disease. , 2008, International journal of cardiology.

[3]  A. Coutinho.  Germ-line selection ensures embryonic autoreactivity and a positive discrimination of self mediated by supraclonal mechanisms. , 2000, Seminars in immunology.

[4]  Dinesh Gupta,et al.  Distribution of proline-rich (PxxP) motifs in distinct proteomes: functional and therapeutic implications for malaria and tuberculosis. , 2004, Protein engineering, design & selection : PEDS.

[5]  R. Barst,et al.  Primary pulmonary hypertension: immunogenetic response to high‐mobility group (HMG) proteins and histone , 1996, Clinical and experimental immunology.

[6]  P. Grammas,et al.  Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp120 proteins. , 2005, Biochemical and biophysical research communications.

[7]  C. Dubuquoy,et al.  Colonization of Gnotobiotic Mice with Human Gut Microflora at Birth Protects Against Escherichia coli Heat-Labile Enterotoxin-Mediated Abrogation of Oral Tolerance , 2003, Pediatric Research.

[8]  W. F. de Azevedo,et al.  Bio-inspired algorithms applied to molecular docking simulations. , 2011, Current medicinal chemistry.

[9]  C. Ferri,et al.  Detection of autoimmunity in early primary Epstein-Barr virus infection by Western blot analysis. , 2008, Clinical and experimental rheumatology.

[10]  F. Arnett,et al.  Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku. , 1992, The American journal of medicine.

[11]  R. Kitamura,et al.  Elevated immunoglobulin G antibodies to the proline‐rich amino‐terminal region of Epstein–Barr virus nuclear antigen‐2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements , 2005, Clinical and experimental immunology.

[12]  R. Coppel,et al.  The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase , 1988, The Journal of experimental medicine.

[13]  R. Speich,et al.  Clinical classification of pulmonary hypertension. , 2004, Journal of the American College of Cardiology.

[14]  F. Etzkorn,et al.  Peptidyl-prolyl isomerase inhibitors. , 2006, Biopolymers.

[15]  A. Gelber,et al.  Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension. , 2003, Arthritis and rheumatism.

[16]  R. Mathew.  Inflammation and Pulmonary Hypertension , 2010, Cardiology in review.

[17]  P. Lardelli,et al.  Detection of anti-interferon-gamma autoantibodies in subjects infected by Mycobacterium tuberculosis. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[18]  Z. Galis,et al.  Matrix metalloproteinase 9 facilitates collagen remodeling and angiogenesis for vascular constructs. , 2005, Tissue engineering.

[19]  M. Pender.  Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. , 2003, Trends in immunology.

[20]  M. Glocker,et al.  Mass Spectrometric and Peptide Chip Epitope Mapping of Rheumatoid Arthritis Autoantigen RA33 , 2009, European journal of mass spectrometry.

[21]  J. Kere,et al.  BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension , 2005, Human mutation.

[22]  M. Humbert,et al.  Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family , 2000, Journal of medical genetics.

[23]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[24]  Maya Ram,et al.  Matrix Metalloproteinase-9 and Autoimmune Diseases , 2006, Journal of Clinical Immunology.

[25]  L. Bačáková,et al.  In vitro hypoxia increases production of matrix metalloproteinases and tryptase in isolated rat lung mast cells. , 2008, Physiological research.

[26]  J. Alcocer-Varela,et al.  Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis. , 2003, Rheumatology.

[27]  Christina Meyer,et al.  IgE–Mediated Reactions to Autoantigens in Allergic Diseases , 1999, International Archives of Allergy and Immunology.

[28]  C. Gordon,et al.  Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus. , 2009, Rheumatology.

[29]  Bo Yao,et al.  EPSVR and EPMeta: prediction of antigenic epitopes using support vector regression and multiple server results , 2010, BMC Bioinformatics.

[30]  J. Kolls,et al.  Interleukin-17A and interleukin-17F: a tale of two cytokines. , 2009, Immunity.

[31]  J. Knowles,et al.  Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[32]  Permanan R Khusial,et al.  The anti-Sm immune response in autoimmunity and cell biology. , 2003, Autoimmunity reviews.

[33]  K. Nakashima,et al.  Epidemiology of Epstein–Barr virus, cytomegalovirus, and kaposi's sarcoma‐associated herpesvirus infections in peripheral blood leukocytes revealed by a multiplex PCR assay , 2006, Journal of medical virology.

[34]  N. Mehra,et al.  Anti-IgG autoantibodies and possible immune regulatory mechanisms in patients with pulmonary tuberculosis. , 1996, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[35]  Philipp Christen,et al.  High affinity binding of hydrophobic and autoantigenic regions of proinsulin to the 70 kDa chaperone DnaK , 2010, BMC Biochemistry.

[36]  Shinn-Ying Ho,et al.  POPISK: T-cell reactivity prediction using support vector machines and string kernels , 2011, BMC Bioinformatics.

[37]  F. Cetani,et al.  Abbreviations used: AD, , 2022 .

[38]  Y. Shoenfeld,et al.  Epstein–Barr Virus and Cytomegalovirus in Autoimmune Diseases , 2007, Annals of the New York Academy of Sciences.

[39]  Y. Bar-dayan,et al.  Autoimmune aspects of primary pulmonary hypertension. , 1995, Pathobiology : journal of immunopathology, molecular and cellular biology.

[40]  M. Campa,et al.  Evidence for autoantibody production associated with polyclonal B-cell activation by Pseudomonas aeruginosa , 1982, Infection and immunity.

[41]  A. Firth,et al.  Idiopathic pulmonary arterial hypertension , 2010, Disease Models & Mechanisms.

[42]  M. Furutani,et al.  Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[43]  Saito,et al.  Fine Specificity of Anti‐Fibrillin‐1 Autoantibodies in Primary Pulmonary Hypertension Syndrome , 2000, Scandinavian journal of immunology.

[44]  F. Schmid,et al.  Prolyl isomerase: enzymatic catalysis of slow protein-folding reactions. , 1993, Annual review of biophysics and biomolecular structure.

[45]  S. Tasneem,et al.  Crossreactivity of SLE Autoantibodies with 70 kDa Heat Shock Proteins of Mycobacterium tuberculosis , 2001, Microbiology and immunology.

[46]  S. Bhattacharya,et al.  Possible role of superantigens in inducing autoimmunity in pemphigus patients , 2011, The Journal of dermatology.

[47]  G. Folkers,et al.  Immunological and Structural Analysis of IgE-Mediated Cross-Reactivity between Manganese Superoxide Dismutases , 2002, International Archives of Allergy and Immunology.

[48]  E Ruoslahti,et al.  Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library , 1994, The Journal of cell biology.

[49]  J. Esquivel-Valerio,et al.  Antineutrophil cytoplasm autoantibodies in patients with tuberculosis are directed against bactericidal/permeability increasing protein and are detected after treatment initiation. , 2010, Clinical and experimental rheumatology.

[50]  M. Humbert,et al.  BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension , 2006, Human mutation.

[51]  D. Playford,et al.  Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis , 2009, Internal medicine journal.

[52]  D. Fox,et al.  Th17 cells in human disease , 2008, Immunological reviews.

[53]  K. Bendtzen,et al.  Auto‐Antibodies to Tumour Necrosis Factor a in Healthy Humans and Patients with Inflammatory Diseases and Gram‐Negative Bacterial Infections , 1989, Scandinavian journal of immunology.

[54]  Amos Bairoch,et al.  ScanProsite: a reference implementation of a PROSITE scanning tool. , 2002, Applied bioinformatics.

[55]  S. Mani,et al.  HIV and Pulmonary Hypertension: A Review , 1994, Southern medical journal.

[56]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[57]  M. Rosen,et al.  Pulmonary Arterial Hypertension in Human Immunodeficiency Virus Infection , 2009, Postgraduate medicine.

[58]  J. I. Hoffman.  Comparison of Two Groups: t-Tests and Nonparametric Tests , 2015 .

[59]  Y. Shoenfeld,et al.  Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. , 1986, Clinical and experimental immunology.

[60]  N. Morrell.  Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling? , 2006, Proceedings of the American Thoracic Society.

[61]  Richard T. Lee,et al.  Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. , 2006, American journal of physiology. Heart and circulatory physiology.

[62]  P. Kao,et al.  High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension. , 2002, Chest.

[63]  F. Smith,et al.  Microvascular cytomegalovirus endothelialitis of the lung: a possible cause of secondary pulmonary hypertension in a patient with AIDS. , 1998, Chest.

[64]  J. Harley,et al.  Linear epitope mapping of an Sm B/B' polypeptide. , 1992, Journal of immunology.

[65]  J. Roudier,et al.  Epstein-Barr virus in autoimmune diseases. , 2008, Best practice & research. Clinical rheumatology.

[66]  R. Girgis,et al.  HIV‐associated pulmonary arterial hypertension: a clinical problem that is here to stay? , 2009, International journal of clinical practice. Supplement.

[67]  M. Landini,et al.  Human cytomegalovirus targets different subsets of antigen‐presenting cells with pathological consequences for host immunity: implications for immunosuppression, chronic inflammation and autoimmunity , 2009, Reviews in medical virology.

[68]  C. Guarneri,et al.  The human Ku autoantigen shares amino acid sequence homology with fungal, but not bacterial and viral, proteins , 2011, Immunopharmacology and immunotoxicology.

[69]  J. Novotná,et al.  Exposure to chronic hypoxia induces qualitative changes of collagen in the walls of peripheral pulmonary arteries. , 1997, Life sciences.

[70]  J. Novotná,et al.  Acute and chronic hypoxia as well as 7‐day recovery from chronic hypoxia affects the distribution of pulmonary mast cells and their MMP‐13 expression in rats , 2006, International journal of experimental pathology.

[71]  C. Carter.  Pathogen and autoantigen homologous regions within the cystic fibrosis transmembrane conductance regulator (CFTR) protein suggest an autoimmune treatable component of cystic fibrosis. , 2011, FEMS immunology and medical microbiology.

[72]  Gajendra PS Raghava,et al.  Identification of conformational B-cell Epitopes in an antigen from its primary sequence , 2010, Immunome research.

[73]  E. Telemo,et al.  A Full Flora, but not Monocolonization by Escherichia coli or Lactobacilli, Supports Tolerogenic Processing of a Fed Antigen , 2005, Scandinavian journal of immunology.

[74]  J. Feder,et al.  Cleavage site specificity of vertebrate collagenases. , 1986, Biochemical and biophysical research communications.

[75]  F. Maquart,et al.  Matrikines in the regulation of extracellular matrix degradation. , 2005, Biochimie.

[76]  V. Ferrans,et al.  Effects of human cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells. , 1999, Circulation.

[77]  R. Busse,et al.  Hospitalisation Costs of Cystic Fibrosis , 2012, PharmacoEconomics.

[78]  R. Longnecker,et al.  Epstein–Barr virus LMP2A imposes sensitivity to apoptosis , 2010, The Journal of general virology.

[79]  I. Berdicevsky,et al.  Incidence of Candida in psoriasis – a study on the fungal flora of psoriatic patients , 2001, Mycoses.

[80]  J. Perfect,et al.  Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[81]  Dominique Chu.  Modes of evolution in a parasite-host interaction: Dis-entangling factors determining the evolution of regulated fimbriation in E. coli , 2009, Biosyst..

[82]  H. Date,et al.  Prednisolone Inhibits Proliferation of Cultured Pulmonary Artery Smooth Muscle Cells of Patients With Idiopathic Pulmonary Arterial Hypertension , 2005, Circulation.

[83]  J. Kubrycht,et al.  Length of the hypermutation motif DGYW/WRCH in the focus of statistical limits. Implications for a double-motif or extended motif recognition models. , 2008, Journal of theoretical biology.